Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
D000284:Administration, Oral; D000818:Animals; D000906:Antibodies / Q000032:analysis; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000592:standards*; D001639:Bicarbonates / Q000494:pharmacology; D003967:Diarrhea / Q000276:immunology; D004405:Dysentery, Bacillary / Q000276:immunology*; D004926:Escherichia coli / Q000276:immunology / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D006168:Guinea Pigs; D006386:Hemagglutination Tests; D006801:Humans; D006822:Hybrid Cells; D007110:Immunity, Active; D007413:Intestinal Mucosa / Q000187:drug effects; D008297:Male; D009154:Mutation; D012760:Shigella / Q000276:immunology*; D012763:Shigella flexneri / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism / Q000472:pathogenicity; D013307:Streptomycin / Q000378:metabolism; D014774:Virulence
D000906:Antibodies; D001428:Bacterial Vaccines; D001639:Bicarbonates; D013307:Streptomycin